Multi-institutional analysis of stereotactic body radiotherapy for sarcoma pulmonary metastases: High rates of local control with favorable toxicity.
Brian C BaumannKaren De Amorim BernsteinThomas F DeLaneyCharles B SimoneJames D KolkerEdwin ChoyWilliam P LevinKristy L WeberAshok MuniappanAbigail T BermanArthur StaddonLee HartnerBrian Van TineAngela HirbeEli GlatsteinStephen M HahnSuneel N NagdaYen-Lin ChenPublished in: Journal of surgical oncology (2020)
In the first multi-institutional series on SBRT for sarcoma PM's, SBRT has excellent LC and is well-tolerated. SBRT should be considered as an alternative/complement to resection.